Business · 25 February 2026

Novo Nordisk Ozempic cost drops to $675

Danish drugmaker Novo Nordisk announced plans to lower the United States list price of its diabetes drug Ozempic. The monthly cost for Ozempic will decrease to $675, which is about a third less than its current $1,027 price. These price reductions will begin on 1 January 2027 and will apply to all patients, regardless of insurance. Novo Nordisk aims to improve affordability and access for Americans.

By BriefTea Editorial · 25 February 2026 at 17:36

Reported by Reuters · How we write briefs

Get the app

More briefs

BusinessIceland supermarket boss tells the Chancellor to cut business taxes for employers BusinessNorwich trains face disruption in September and October for rail works BusinessEngland's free bus pass age will rise to 67 by April 2028 BusinessBritish tourist visits to Japan up 40.8% since 2019 TechnologyGoogle paying £260m to settle UK Play Store developer lawsuit BusinessSnack makers warn new UK rules could undo years of reformulation work More business stories → Browse all stories →